Ignite Creation Date:
2025-12-24 @ 9:22 PM
Ignite Modification Date:
2026-06-04 @ 6:06 AM
Study NCT ID:
NCT00621504
Status:
COMPLETED
Last Update Posted:
2017-03-14
First Post:
2008-02-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia
Sponsor:
Forest Laboratories
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Bacterial Pneumonia | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | ceftaroline | View |
| None | Community-acquired pneumonia | View |
| None | CAP | View |
| None | IV (intravenous) | View |
| None | Streptococcus pneumoniae | View |
| None | Haemophilus influenzae | View |
| None | Mycoplasma pneumoniae | View |
| None | Chlamydophila spp | View |
| None | Legionella spp | View |
| None | Multi-drug resistant Streptococcus pneumoniae (MDRSP) | View |
| None | antimicrobial resistance | View |
| None | pneumococci | View |
| None | Ceftriaxone | View |
| None | bacteria | View |
| None | ß-lactam | View |
| None | beta-lactam | View |
| None | antibiotic | View |